Works matching AU Cherney, David Z. I.

Results: 100
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.

    Published in:
    Nephrology Dialysis Transplantation, 2025, v. 40, n. 4, p. 720, doi. 10.1093/ndt/gfae203
    By:
    • Mayne, Kaitlin J;
    • Sardell, Rebecca J;
    • Staplin, Natalie;
    • Judge, Parminder K;
    • Zhu, Doreen;
    • Sammons, Emily;
    • Cherney, David Z I;
    • Green, Jennifer B;
    • Levin, Adeera;
    • Pontremoli, Roberto;
    • Hauske, Sibylle J;
    • Emberson, Jonathan;
    • Preiss, David;
    • Landray, Martin J;
    • Baigent, Colin;
    • Wanner, Christoph;
    • Haynes, Richard;
    • Herrington, William G;
    • Group, the EMPA-KIDNEY Collaborative
    Publication type:
    Article
    10
    11

    Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.

    Published in:
    Nephrology Dialysis Transplantation, 2025, v. 40, n. 2, p. 308, doi. 10.1093/ndt/gfae132
    By:
    • Heerspink, Hiddo J L;
    • Agarwal, Rajiv;
    • Bakris, George L;
    • Cherney, David Z I;
    • Lam, Carolyn S P;
    • Neuen, Brendon L;
    • Sarafidis, Pantelis A;
    • Tuttle, Katherine R;
    • Wanner, Christoph;
    • Brinker, Meike D;
    • Dizayee, Sara;
    • Kolkhof, Peter;
    • Schloemer, Patrick;
    • Vesterinen, Paula;
    • Perkovic, Vlado;
    • investigators, for the FIND-CKD
    Publication type:
    Article
    12
    13
    14
    15

    The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.

    Published in:
    Nephrology Dialysis Transplantation, 2020, v. 35, n. 10, p. 1700, doi. 10.1093/ndt/gfaa234
    By:
    • Wheeler, David C;
    • Stefansson, Bergur V;
    • Batiushin, Mikhail;
    • Bilchenko, Oleksandr;
    • Cherney, David Z I;
    • Chertow, Glenn M;
    • Douthat, Walter;
    • Dwyer, Jamie P;
    • Escudero, Elizabeth;
    • Pecoits-Filho, Roberto;
    • Furuland, Hans;
    • Górriz, José Luis;
    • Greene, Tom;
    • Haller, Hermann;
    • Hou, Fan Fan;
    • Kang, Shin-Wook;
    • Isidto, Rey;
    • Khullar, Dinesh;
    • Mark, Patrick B;
    • McMurray, John J V
    Publication type:
    Article
    16

    The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial.

    Published in:
    Nephrology Dialysis Transplantation, 2020, v. 35, n. 5, p. 895, doi. 10.1093/ndt/gfz294
    By:
    • Opingari, Erika;
    • Verma, Subodh;
    • Connelly, Kim A;
    • Mazer, Cyril David;
    • Teoh, Hwee;
    • Quan, Adrian;
    • Zuo, Fei;
    • Pan, Yi;
    • Bhatt, Deepak L;
    • Zinman, Bernard;
    • Leiter, Lawrence A;
    • Yan, Andrew T;
    • Cherney, David Z I;
    • Gilbert, Richard E
    Publication type:
    Article
    17
    18
    19
    20
    21

    Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes.

    Published in:
    Diabetes Care, 2018, v. 41, n. 12, p. 2570, doi. 10.2337/dc18-1236
    By:
    • Lovshin, Julie A.;
    • Bjornstad, Petter;
    • Lovblom, Leif E.;
    • Bai, Johnny-Wei;
    • Lytvyn, Yuliya;
    • Boulet, Geneviève;
    • Farooqi, Mohammed A.;
    • Santiago, Sam;
    • Orszag, Andrej;
    • Scarr, Daniel;
    • Weisman, Alanna;
    • Keenan, Hillary A.;
    • Brent, Michael H.;
    • Paul, Narinder;
    • Bril, Vera;
    • Perkins, Bruce A.;
    • Cherney, David Z. I.
    Publication type:
    Article
    22
    23
    24

    Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.

    Published in:
    Diabetes Care, 2018, v. 41, n. 4, p. 831, doi. 10.2337/dc17-2475
    By:
    • Bjornstad, Petter;
    • Lovshin, Julie A.;
    • Lytvyn, Yuliya;
    • Boulet, Genevieve;
    • Lovblom, Leif E.;
    • Alhuzaim, Omar N.;
    • Farooqi, Mohammed A.;
    • Lai, Vesta;
    • Tse, Josephine;
    • Cham, Leslie;
    • Orszag, Andrej;
    • Scarr, Daniel;
    • Weisman, Alanna;
    • Keenan, Hillary A.;
    • Brent, Michael H.;
    • Paul, Narinder;
    • Bril, Vera;
    • Perkins, Bruce A.;
    • Cherney, David Z. I.
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 575, doi. 10.1111/dom.13556
    By:
    • Bjornstad, Petter;
    • Singh, Sunita K.;
    • Snell‐Bergeon, Janet K.;
    • Lovshin, Julie A.;
    • Lytvyn, Yuliya;
    • Lovblom, Leif E.;
    • Rewers, Marian J.;
    • Boulet, Genevieve;
    • Lai, Vesta;
    • Tse, Josephine;
    • Cham, Leslie;
    • Orszag, Andrej;
    • Weisman, Alanna;
    • Keenan, Hillary A.;
    • Brent, Michael H.;
    • Paul, Narinder;
    • Bril, Vera;
    • Perkins, Bruce A.;
    • Cherney, David Z. I.
    Publication type:
    Article
    45
    46

    Evaluation of the Pharmacokinetics and Exposure–Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease.

    Published in:
    Clinical Pharmacokinetics, 2021, v. 60, n. 4, p. 517, doi. 10.1007/s40262-020-00956-1
    By:
    • van der Aart-van der Beek, Annemarie B.;
    • Koomen, Jeroen V.;
    • Dekkers, Claire C. J.;
    • Barbour, Sean J.;
    • Boulton, David W.;
    • Gansevoort, Ron T.;
    • Greasley, Peter J.;
    • Abdul Gafor, Abdul Halim;
    • Laverman, Gozewijn D.;
    • Li, Qiang;
    • Lim, Soo Kun;
    • Stevens, Jasper;
    • Vervloet, Marc G.;
    • Singh, Sunita;
    • Cattran, Daniel C.;
    • Reich, Heather N.;
    • Cherney, David Z. I.;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    47
    48

    Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial.

    Published in:
    European Heart Journal, 2025, v. 46, n. 12, p. 1096, doi. 10.1093/eurheartj/ehae613
    By:
    • Mahaffey, Kenneth W;
    • Tuttle, Katherine R;
    • Arici, Mustafa;
    • Baeres, Florian M M;
    • Bakris, George;
    • Charytan, David M;
    • Cherney, David Z I;
    • Chernin, Gil;
    • Correa-Rotter, Ricardo;
    • Gumprecht, Janusz;
    • Idorn, Thomas;
    • Pugliese, Giuseppe;
    • Rasmussen, Ida Kirstine Bull;
    • Rasmussen, Søren;
    • Rossing, Peter;
    • Sokareva, Ekaterina;
    • Mann, Johannes F E;
    • Perkovic, Vlado;
    • Pratley, Richard
    Publication type:
    Article
    49
    50